Sentinel lymphatic mapping in breast cancer

Journal of the American College of Surgeons

Volumn 188, Issue 5, 1999, Pages 545-549

  Hill, Arnold D K ^a   Mann, G Bruce ^a   Borgen, Patrick I ^a   Cody III, Hiram S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; ISOTOPE;

BREAST CANCER; CANCER STAGING; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; PRIORITY JOURNAL; REVIEW; TECHNIQUE;

AXILLA; BIOPSY; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; RADIOPHARMACEUTICALS;

EID: 0032952690     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(99)00017-4     Document Type: Review

References (41)

1. Fisher B, Ravdin RG, Ausman RK, et al. Surgical adjuvant chemotherapy in cancer of the breast: results of a cooperative investigation. Ann Surg 1968;168:337-356.
2. Bonadonna G, Valagussa P, Moliterni A, et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 1995;332:901-906.
3. Cabanas R. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
4. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
5. Brady MS, Coit DG. Sentinel lymph node evaluation in melanoma. Arch Dermatol 1997;133:1014-1020.
6. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-278.
7. Hultborn KA, Larsson LG, Ragnhult I. The lymph drainage from the breast to the axillary and parasternal lymph nodes, studied with the aid of colloidal Au198. Acta Radiol 1955;43:52-64.
8. Turner-Warwick RT. The lymphatics of the breast. Br J Surg 1959; 46:574-582.
9. Uren RF, Howman-Giles RB, Thompson GF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995;36: 1775-1783.
10. Cody HS, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 1995;2:32-37.
11. Veronesi U, Cascinelli N, Greco M. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985;202:702-707.
12. Veronesi U, Cascinelli N, Bufalino R. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 1983;198:681-684.
13. Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinuous or "skip" metastases in breast carcinoma. Ann Surg 1983;197: 276-283.
14. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
15. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymphnode in breast cancer. Lancet 1997;349: 1668-1669.
16. Folscher DJ, Langman G, Panieri E, et al. Sentinel axillary lymph node: helpful in axillary management in patients with breast cancer? Br J Surg 1997;84:1586.
17. Strand SE, Persson BRR. Quantitative lymphoscintigraphy: basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 1979;20:1038-1046.
18. Krag DN, Ashikaga T, Harlow SP, Weaver DL. Development of sentinel node targeting technique in breast cancer patients. Breast J 1998;4:67-74.
19. Frier M, Griffiths P, Ramsey A. The physical and chemical characteristics of sulphur colloids. Eur J Nucl Med 1981;6:255-260.
20. deVries J. Combined detection technique of radioactive tracer and blue dye for sentinel node biopsy in breast cancer [abstract]. SSO Abstracts 1998;98:WP70.
21. Bares R, Muller B, Fass J, et al. The radiation dose to surgical personnel during intraoperative radioimmunoscintimetry. Eur J Nucl Med 1992;19:110-112.
22. Kuhn JA, Corbisiero RM, Buras RR, et al. Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer. Arch Surg 1991;126:1398-1403.
23. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node miciometastases from breast carcinoma: reviewing the dilemma. Cancer 1997;80:1188-1197.
24. Giuliano AE, Barth AM, Spivack B, et al. Incidence and predictors of axillary metastases in T1 carcinoma of the breast. J Am Coll Surg 1996;183:185-189.
25. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.
26. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-340.
27. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998; 339:941-946.
28. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822.
29. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;5:645-653.
30. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186:275-283.
31. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-1867.
32. O'Hea BJ, Hill ADK, El-Shirbiny A, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-427.
33. Pijpers R, Hoekstra OS, Collet GJ, et al. Impact of lymphoscintigraphy on sentinel node identification with technitium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366-368.
34. Meijer S, Collet GJ, Pijpers HJ, et al. Less axillary dissection necessary due to sentinel node biopsy in patients with breast carcinoma. Ned Tijdschr Geneeskd 1996;140:2239-2243.
35. Nieweg OE, Kapteijn BA, Peterse JL, et al. Identification of the sentinel node in patients with breast carcinoma. Ned Tijdschr Geneeskd 1996;140:2235-2239.
36. Roumen RMH, Valkenburg JGM, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997;23:495-502.
37. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336-340.
38. Galimberti V, Zurrida S, Zucali P, Luini A. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? Breast 1998;7:8-10.
39. Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998;5:126-130.
40. Offodile R, Hoh C, Barsky SH, et al. Minimally invasive breast cancer staging using lymphatic mapping with radiolabeled dextran. Cancer 1998;82:1704-1708.
41. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253-2260.